Target intelligence / Profile preview

Bacterial thiol-containing proteins

Molecular classification
Enzyme, Other
01

Overview

Bacterial thiol-containing proteins are a diverse group of molecules characterized by the presence of reactive sulfhydryl (-SH) groups, primarily located on cysteine residues. These proteins are fundamental to bacterial physiology, serving critical roles in maintaining redox homeostasis, facilitating enzymatic catalysis in metabolic pathways, and ensuring proper protein folding through disulfide bond formation (Fahey, 2013). In the context of infectious diseases, these proteins are essential for bacterial survival and the ability to withstand oxidative stress imposed by the host immune system. Many antimicrobial agents, including heavy metal ions like silver and organomercurials, exert their bactericidal effects by binding to these thiols, which causes widespread protein dysfunction and metabolic collapse (Lemire et al., 2013). Modern drug discovery also explores more selective inhibitors, such as auranofin, which targets specific thiol-dependent enzymes like thioredoxin reductase to treat multi-drug resistant infections (Harbut et al., 2015). Despite their efficacy, the primary challenge in targeting these proteins is achieving selectivity over human thiol-containing proteins to minimize systemic toxicity.

Other names
Bacterial sulfhydryl-containing proteinsBacterial protein thiolsBacterial cysteine-containing proteins
02

Mechanism of action

Antimicrobial agents targeting these proteins typically act through covalent modification, S-nitrosylation, or coordination with the sulfhydryl (-SH) group of cysteine residues. This interaction leads to the irreversible inhibition of essential enzymatic activities, disruption of cellular redox balance, and the denaturation of structural proteins, ultimately resulting in bacterial cell death (Lemire et al., 2013; Harbut et al., 2015).

03

Biological functions

Redox homeostasisEnzymatic catalysisProtein foldingAntioxidant defenseMetal ion coordination
04

Disease associations

Infection
05

Safety considerations

Potential cross-reactivity with human thiol-containing proteins leading to host toxicitySystemic toxicity associated with heavy metal-based agentsDevelopment of bacterial resistance through increased production of low-molecular-weight thiols like bacillithiol or glutathioneLimited therapeutic index for systemic administration
06

Interacting drugs

Silver nitrate

5 more in the full profile.

07

Biomarkers

Intracellular thiol concentrationReactive oxygen species (ROS) levelsProtein carbonylationThioredoxin reductase activity

Beyond the preview

Go deeper on Bacterial thiol-containing proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial thiol-containing proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call